Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus L Quek

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
The Journal of Urology|August 24, 2021
Systematic versus Targeted Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy among Men with Visible LesionsHiten D Patel, Elizabeth L Koehne, Steven M Shea, et al.
Journal of Robotic Surgery|February 8, 2024
Risk of pseudoaneurysm and bleeding complications after partial nephrectomy: comparison of tumor enucleation to standard margin techniqueGoran Rac, Jeffrey L Ellis, Sarang Janakiraman, et al.
BJUI Compass|February 19, 2024
Variability in prostate cancer detection among radiologists and urologists using MRI fusion biopsyHiten D Patel, Whitney R Halgrimson, Sarah E Sweigert, et al.
Urologic Oncology|June 18, 2024
MRI at diagnostic versus confirmatory biopsy during MRI-based active surveillance of prostate cancerMadison Marras, Jeffrey L Ellis, Olivia Copelan, et al.
BJU International|June 23, 2022
A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculatorsHiten D Patel, Elizabeth L Koehne, Steven M Shea, et al.
Anticancer Research|April 4, 2008
Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancerRyutaro Mori, Qingcai Wang, Marcus L Quek, et al.
Urologic Oncology|May 13, 2022
Percentage of sarcomatoid histology is associated with survival in renal cell carcinoma: Stratification and implications by clinical metastatic stageHiten D Patel, Amy Man, Elizabeth L Koehne, et al.
Urology Practice|November 1, 2023
Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle-Invasive Bladder Cancer: Elective and Eligibility Factors Impacting UtilizationHiten D Patel, Ushasi Naha, Victor S Chen, et al.
Urology|September 11, 2016
Functional Implications of Renal Tumor Enucleation Relative to Standard Partial NephrectomyRobert H Blackwell, Belinda Li, Zachary Kozel, et al.
Frontiers in Cellular and Infection Microbiology|April 24, 2023
Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancerChristopher James, Kayeromi Gomez, Shalin Desai, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
The Journal of Urology|August 24, 2021
Systematic versus Targeted Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy among Men with Visible LesionsHiten D Patel, Elizabeth L Koehne, Steven M Shea, et al.
Journal of Robotic Surgery|February 8, 2024
Risk of pseudoaneurysm and bleeding complications after partial nephrectomy: comparison of tumor enucleation to standard margin techniqueGoran Rac, Jeffrey L Ellis, Sarang Janakiraman, et al.
BJUI Compass|February 19, 2024
Variability in prostate cancer detection among radiologists and urologists using MRI fusion biopsyHiten D Patel, Whitney R Halgrimson, Sarah E Sweigert, et al.
Urologic Oncology|June 18, 2024
MRI at diagnostic versus confirmatory biopsy during MRI-based active surveillance of prostate cancerMadison Marras, Jeffrey L Ellis, Olivia Copelan, et al.
BJU International|June 23, 2022
A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculatorsHiten D Patel, Elizabeth L Koehne, Steven M Shea, et al.
Anticancer Research|April 4, 2008
Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancerRyutaro Mori, Qingcai Wang, Marcus L Quek, et al.
Urologic Oncology|May 13, 2022
Percentage of sarcomatoid histology is associated with survival in renal cell carcinoma: Stratification and implications by clinical metastatic stageHiten D Patel, Amy Man, Elizabeth L Koehne, et al.
Urology Practice|November 1, 2023
Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle-Invasive Bladder Cancer: Elective and Eligibility Factors Impacting UtilizationHiten D Patel, Ushasi Naha, Victor S Chen, et al.
Urology|September 11, 2016
Functional Implications of Renal Tumor Enucleation Relative to Standard Partial NephrectomyRobert H Blackwell, Belinda Li, Zachary Kozel, et al.
Frontiers in Cellular and Infection Microbiology|April 24, 2023
Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancerChristopher James, Kayeromi Gomez, Shalin Desai, et al.
Pageof 12